Tarsus Pharmaceuticals Inc (TARS)
SG&A Expenses
$526.44M
TTM · Period ending: · USD
TARS SG&A Expenses
Latest reported$526.44Mperiod ending
Latest reported$526.44Mperiod ending
TARS TTM SG&A Expenses ($825.50K → $526.44M)
TTM SG&A Expenses
High-resolution chart · PNG
TARS sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 526,440,999 | |
| 478,756,999 | |
| 427,322,999 | |
| 365,671,000 | |
| 314,948,000 | |
| 270,727,000 | |
| 237,310,000 | |
| 211,285,000 | |
| 183,699,000 | |
| 144,866,000 | |
| 108,129,000 | |
| 79,757,000 | |
| 61,216,000 | |
| 51,633,000 | |
| 44,738,000 | |
| 36,877,000 | |
| 31,765,000 | |
| 28,183,000 | |
| 25,397,000 | |
| 22,515,000 | |
| 17,994,000 | |
| 12,726,000 | |
| 8,172,000 | |
| 4,669,000 | |
| 2,733,000 | |
| 1,319,250 | |
| 825,500 |